FDA places partial hold on clinical trials of venetoclax for myeloma
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on all clinical trials evaluating venetoclax for the investigational treatment of multiple myeloma.
EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on all clinical trials evaluating venetoclax for the investigational treatment of multiple myeloma.